November 3, 2021 – First HD-CAB Advisory Board

Seven members of the PTC Therapeutics team joined 11 HD-CAB team members for an advisory board on the 3^rd November.  Sian O’Neill, Senior Director of Patient Engagement EMEA & AP wrote following the meeting to say “Thank you again for the opportunity to participate in the 1^st HD-CAB. It was a pleasure to meet such an amazing group of people. The CAB team has pushed the PTC team into overdrive! The real and honest sharing of the reality of HD has generated a lot of questions and dare I say shifted the thought process for our team.”